Breaking News Instant updates and real-time market news.

GE

General Electric

$8.82

0.315 (3.70%)

14:20
01/10/19
01/10
14:20
01/10/19
14:20

General Electric shares up 32c revive hopes for massive weekly call vertical

General Electric shares up 32c revive hopes for massive weekly call vertical. Shares up 31c, or 3.6%, to $8.81 this afternoon with calls leading puts 3:2 and a notable focus at the 9 strike, where over 100K calls are open, most from last Friday's buyer of 75K Jan11th 9/9.5 call spreads for 2c. Shares did briefly pass $9 on Tuesday morning, before sliding back to yesterday's $8.50 close. At current level the spread is worth about 4c, but a move to the upside could get exciting as the delta of the 9 calls, currently 20, would approach 100 very quickly on such short term options, which may involve a rehedge of up to 7.5M shares in order for the seller to remain flat.

  • 31

    Jan

GE General Electric
$8.82

0.315 (3.70%)

12/13/18
12/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Electric (GE) upgraded to Neutral from Underweight at JPMorgan with analyst Stephen Tusa saying he's less negative on the shares with the abating of "known unknowns." 2. Five Below (FIVE) upgraded to Buy from Neutral at Goldman Sachs with analyst Christopher Prykull saying the 18% decline in the stock price over the past month is "disconnected" from the company's robust fundamentals and believes that there is a 20% upside to his price target. 3. Tractor Supply (TSCO) upgraded to Buy from Hold at Deutsche Bank with analyst Michael Baker citing valuation. 4. Procter & Gamble (PG) upgraded to Buy from Neutral at BofA/Merrill with analyst Olivia Tong saying after meetings with CFO Jon Moeller, she believes that the company's early momentum in Q1 of FY19 can be sustained. 5. Dycom (DY) upgraded to Buy from Hold at Craig-Hallum with analyst Christian Schwab saying he believes shares at current levels have become attractive again. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/19/18
VERT
12/19/18
UPGRADE
VERT
Buy
General Electric upgraded to Buy from Hold at Vertical Research
Vertical Research analyst Jeffrey Sprague upgraded General Electric to Buy from Hold with an $11 price target.
12/19/18
12/19/18
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Medtronic (MDT) upgraded to Overweight from Neutral at JPMorgan with analyst Robert Marcus saying that over the past year he's seen a "significant turnaround in performance" at Medtronic. 2. Masimo (MASI) upgraded to Overweight from Neutral at Piper Jaffray with analyst William Quirk saying management, during recent meetings, was upbeat about their near- and longer-term prospects of driving 8%-10% sales growth, at least 100 basis points of operating margin improvement and the company's 30% operating profit goal. 3. Darden (DRI) upgraded to Buy from Hold at Maxim and to Buy from Neutral at BTIG. 4. Best Buy (BBY) upgraded to Neutral, risks priced in, says MoffettNathanson with analyst Greg Melich saying sales and margin risks are reflected in valuation. 5. General Electric (GE) upgraded to Buy from Hold at Vertical Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/07/19
JPMS
01/07/19
NO CHANGE
Target $6
JPMS
Neutral
JPMorgan sees GE providing something 'more tangible' soon, keeps $6 target
JPMorgan analyst Stephen Tusa says his conversations with clients continue to be dominated by the debate around General Electric's liabilities. The analyst has seen nothing to change his view that $100B of net liabilities and zero enterprise free cash flow is the problem facing management and the right construct when thinking about how to get the story back to "normal" from an equity value standpoint. We are likely approaching the time where GE will provide something "more tangible, perhaps shrinking the balance sheet," Tusa tells investors in a research note. However, related dilution, combined with a full "cleanse" of the accounting structure, should result in a "substantially lower run rate fundamental anchor than many appreciate," says Tusa. He keeps a Neutral rating on GE shares with a $6 price target. The analyst believes Bloomberg's report of Apollo interest in GE's jet leasing business is "not enough value to change" the company's "leverage problem," which he says is "punctuated" by the "collapse in lessor peer multiples."

TODAY'S FREE FLY STORIES

07:05
01/22/19
01/22
07:05
01/22/19
07:05
General news
Global stock markets under pressure after gloomy IMF report. »

Global stock markets…

BG

Bunge

$52.95

0.745 (1.43%)

07:04
01/22/19
01/22
07:04
01/22/19
07:04
Hot Stocks
Bunge sees FY18 total segment adjusted EBIT below previously disclosed range »

The company provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPGP

IPG Photonics

$132.54

3.37 (2.61%)

07:04
01/22/19
01/22
07:04
01/22/19
07:04
Hot Stocks
IPG Photonics to acquire Padtec SND »

IPG Photonics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$126.64

1.37 (1.09%)

07:04
01/22/19
01/22
07:04
01/22/19
07:04
Hot Stocks
Centene subsidiary selected by Arizona's Department of Corrections »

Centene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 28

    May

QURE

uniQure

$31.29

-0.02 (-0.06%)

07:04
01/22/19
01/22
07:04
01/22/19
07:04
Hot Stocks
uniQure announces FDA clearance of AMT-130 NDA in Huntington's disease »

uniQure N.V. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNCE

Concert Pharmaceuticals

$14.21

-0.065 (-0.46%)

07:04
01/22/19
01/22
07:04
01/22/19
07:04
Hot Stocks
Concert completes enrollment of 12 mg cohort in CTP-543 Phase 2a trial »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 30

    Jan

  • 12

    Feb

  • 13

    Feb

RCKT

Rocket Pharmaceuticals

$16.00

0.23 (1.46%)

07:03
01/22/19
01/22
07:03
01/22/19
07:03
Hot Stocks
Rocket Pharmaceuticals announces FDA clearance of IND application for RP-A501 »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTI

Pluristem

$1.12

(0.00%)

07:03
01/22/19
01/22
07:03
01/22/19
07:03
Hot Stocks
Pluristem to collaborate with IDF in treatment of burn injuries »

Pluristem Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRY

Tilray

$77.14

-6.17 (-7.41%)

07:02
01/22/19
01/22
07:02
01/22/19
07:02
Hot Stocks
Tilray to acquire Natura Naturals for up to C$70M »

Tilray announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$52.95

0.745 (1.43%)

, CAG

Conagra Brands

$21.58

0.34 (1.60%)

07:02
01/22/19
01/22
07:02
01/22/19
07:02
Hot Stocks
Bunge names Gregory Heckman as acting CEO »

Bunge (BG) announced that…

BG

Bunge

$52.95

0.745 (1.43%)

CAG

Conagra Brands

$21.58

0.34 (1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

CGEN

Compugen

$3.18

0.07 (2.25%)

07:02
01/22/19
01/22
07:02
01/22/19
07:02
Hot Stocks
Compugen announces publication of preclinical data on PVRIG »

Compugen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$110.57

6.4 (6.14%)

07:00
01/22/19
01/22
07:00
01/22/19
07:00
Recommendations
Kansas City Southern analyst commentary  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRV

Travelers

$123.97

1.03 (0.84%)

06:58
01/22/19
01/22
06:58
01/22/19
06:58
Hot Stocks
Travelers reports Q4 consolidated combined ratio of 97.5% »

Fourth quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

TRV

Travelers

$123.97

1.03 (0.84%)

06:58
01/22/19
01/22
06:58
01/22/19
06:58
Hot Stocks
Travelers reports Q4 book value per share $86.84 »

Book value per share of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

CONN

Conn's

$19.65

0.31 (1.60%)

06:57
01/22/19
01/22
06:57
01/22/19
06:57
Recommendations
Conn's analyst commentary  »

Conn's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$12.41

-0.07 (-0.56%)

06:57
01/22/19
01/22
06:57
01/22/19
06:57
Hot Stocks
Amneal Pharmaceuticals appoints Todd Branning as CFO »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TRV

Travelers

$123.97

1.03 (0.84%)

06:57
01/22/19
01/22
06:57
01/22/19
06:57
Earnings
Travelers reports Q4 core EPS $2.13, consensus $2.33 »

Reports Q4 revenue $7.8B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

AINV

Apollo Investment

$14.51

-0.01 (-0.07%)

06:57
01/22/19
01/22
06:57
01/22/19
06:57
Upgrade
Apollo Investment rating change  »

Apollo Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

IDXG

Interpace Diagnostics

$1.07

(0.00%)

, LH

LabCorp

$137.67

2.42 (1.79%)

06:57
01/22/19
01/22
06:57
01/22/19
06:57
Hot Stocks
Interpace finalizes validation of third specimen of ThyGeNEX and ThyraMIR »

Interpace Diagnostics…

IDXG

Interpace Diagnostics

$1.07

(0.00%)

LH

LabCorp

$137.67

2.42 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 07

    Feb

  • 18

    May

ZBH

Zimmer Biomet

$105.33

-0.83 (-0.78%)

06:55
01/22/19
01/22
06:55
01/22/19
06:55
Recommendations
Zimmer Biomet analyst commentary  »

Zimmer Biomet price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 01

    Feb

LCI

Lannett

$7.64

0.15 (2.00%)

06:55
01/22/19
01/22
06:55
01/22/19
06:55
Hot Stocks
Lannett enters U.S. distribution agreement for Trientine Hydrochloride Capsules »

Lannett announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

SDLP

Seadrill Partners

$1.77

0.07 (4.12%)

06:54
01/22/19
01/22
06:54
01/22/19
06:54
Hot Stocks
Seadrill Partners reduces dividend to 1c from 10c »

Seadrill Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNX

Knight-Swift

$32.69

1.005 (3.17%)

06:54
01/22/19
01/22
06:54
01/22/19
06:54
Recommendations
Knight-Swift analyst commentary  »

Knight-Swift generating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSE

Inspired Entertainment

$5.64

(0.00%)

06:53
01/22/19
01/22
06:53
01/22/19
06:53
Conference/Events
Inspired Entertainment management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

IDCC

InterDigital

$72.32

-0.53 (-0.73%)

06:51
01/22/19
01/22
06:51
01/22/19
06:51
Conference/Events
InterDigital management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.